103 results
8-K
EX-99.2
NGNE
Neurogene Inc
4 Mar 24
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett
7:30am
proposed potency cohort in 2024 assay strategy, a first milestone in determining continuation of the program Continue collection of clinical trial data … on vision and motor for analysis Improved Manufacturing Process FDA alignment on proposed comparability strategy for using Ongoing natural history
8-K
EX-99.1
NGNE
Neurogene Inc
4 Mar 24
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett
7:30am
strategy has been to build flexibility and optionality early in the program with two concurrent dose cohorts designed to generate a more complete data
8-K
EX-99.2
NGNE
Neurogene Inc
5 Jan 24
Neurogene Announces Business Update and 2024 Outlook
7:11am
comparability strategy for using Neurogene-made material with substantially improved profile to Phase 1/2 drug product Improved Manufacturing Process FDA … accepted proposed potency assay strategy, a first milestone in determining continuation of the program Potency Assay Complete enrollment of high dose
8-K
EX-99.1
9lm2w
5 Jan 24
Neurogene Announces Business Update and 2024 Outlook
7:11am
8-K
EX-99.4
exmzs4zwdhl2fao
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
4e74goh wa
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-3.3
85y696i9obmc657
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
S-4/A
n51mmw6yymra3u
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.31
zogf885
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.29
ywv45298orpyzkg66hyh
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4
y4le2 m8d4
18 Aug 23
Registration of securities issued in business combination transactions
6:19pm
425
phrqreuzinovu
18 Jul 23
Business combination disclosure
4:02pm